Skip to main content

Articles

Page 2 of 33

  1. Previous studies suggest intestinal dysbiosis is associated with metabolic diseases. However, the causal relationship between them is not fully elucidated. Gut microbiota evaluation of patients with congenital...

    Authors: Renan Magalhães Montenegro Junior, Clarisse Mourão Melo Ponte, Maria Helane Costa Gurgel Castelo, Alessandro Conrado de Oliveira Silveira, Virgínia Oliveira Fernandes, Catarina Brasil D’Alva, Luiz Felipe Valter Oliveira, Angélica Domingues Hristov, Silviane Praciano Bandeira, Grayce Ellen da Cruz Paiva and José Eduardo Levi
    Citation: Diabetology & Metabolic Syndrome 2022 14:136
  2. Salvianolic acid A (SalA) is the main water-soluble component isolated from Salvia miltiorrhiza. This study explored the influences of SalA on intestinal microbiota composition and lipid metabolism in Zucker diab...

    Authors: Xufeng Wang, Xiangjun Sun, Abulikemu Abulizi, Jinyao Xu, Yun He, Qian Chen and Ruicheng Yan
    Citation: Diabetology & Metabolic Syndrome 2022 14:135
  3. There is an increased burden of diabetes globally including in sub-Saharan Africa. The literature shows that glycaemic control among type 2 diabetes patients is poor in most countries in sub-Saharan Africa. Un...

    Authors: Jean-Pierre Fina Lubaki, Olufemi Babatunde Omole and Joel Msafiri Francis
    Citation: Diabetology & Metabolic Syndrome 2022 14:134
  4. Diabetic foot ulcer (DFU) is a common diabetes mellitus (DM) complication. Individuals with DM and a DFU achieved significantly lower scores in cognitive tests than those without a DFU. We investigated whether...

    Authors: Yael Sela, Keren Grinberg, Tali Cukierman-Yaffe and Rachel Natovich
    Citation: Diabetology & Metabolic Syndrome 2022 14:133
  5. We aimed to investigate the joint effect of visit-to-visit variability (VVV) in low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides and glycosylated hemoglo...

    Authors: Panpan He, Xiaoqin Gan, Qimeng Wu, Ziliang Ye, Sisi Yang, Yanjun Zhang, Huan Li, Chun Zhou, Yuanyuan Zhang, Mengyi Liu and Xianhui Qin
    Citation: Diabetology & Metabolic Syndrome 2022 14:132
  6. Ambulatory blood pressure monitoring (ABPM) in patients with diabetes mellitus (DM) and hypertension (HTN) show the dipping patterns, identify masked uncontrolled hypertension (MUCH), and demonstrate the effec...

    Authors: Pop Călin, Manea Viorel, Pruna Luchiana, Cosma Mihaela and Pop Lavinia
    Citation: Diabetology & Metabolic Syndrome 2022 14:130
  7. A main factor contributing to insufficient glycemic control, during basal/bolus insulin therapy, is poor self-management bolus. Insulin bolus administration frequency is strongly associated with glycated hemog...

    Authors: Vanessa Araujo Montanari, Mônica Andrade Lima Gabbay and Sérgio Atala Dib
    Citation: Diabetology & Metabolic Syndrome 2022 14:129
  8. Type 1 diabetes (T1D) and celiac disease (CD) coexist very often. Identification of the human leukocyte antigen (HLA) DQ2/DQ8 can confirm the genetic predisposition to CD. Negative result of this test allows t...

    Authors: Agnieszka Zubkiewicz-Kucharska, Tatiana Jamer, Joanna Chrzanowska, Katarzyna Akutko, Tomasz Pytrus, Andrzej Stawarski and Anna Noczyńska
    Citation: Diabetology & Metabolic Syndrome 2022 14:128
  9. Plasminogen activator inhibitor 1 (PAI-1) also known as serpin E1 or endothelial plasminogen activator inhibitor, is produced from endothelial cells and adipose tissue. PAI-1 inhibits tissue plasminogen activa...

    Authors: Gaber El-Saber Batiha, Hayder M. Al-kuraishy, Thabat J. Al-Maiahy, Ali K. Al-Buhadily, Hebatallah M. Saad, Ali I. Al-Gareeb and Jesus Simal-Gandara
    Citation: Diabetology & Metabolic Syndrome 2022 14:127
  10. Hyperglycemic non-diabetic stroke patients have a worse prognosis than both normoglycemic and diabetic patients. Aim of this study was to assess whether hyperglycemia is an aggravating factor or just an epiphe...

    Authors: Antonio Muscari, Roberta Falcone, Guerino Recinella, Luca Faccioli, Paola Forti, Marco Pastore Trossello, Giovanni M. Puddu, Luca Spinardi and Marco Zoli
    Citation: Diabetology & Metabolic Syndrome 2022 14:126
  11. Interleukin-6 (IL-6) is an inflammation-related cytokine associated with an elevated risk of cardiovascular events. In a previous study, we demonstrated that increased IL-6 was predictive of sub-clinical ather...

    Authors: Márcio Mossmann, Marco Vugman Wainstein, Stéfani Mariani, Guilherme Pinheiro Machado, Gustavo Neves de Araújo, Michael Andrades, Sandro Cadaval Gonçalves and Marcello Casaccia Bertoluci
    Citation: Diabetology & Metabolic Syndrome 2022 14:125
  12. As one of the severe complications of diabetes mellitus, diabetic retinopathy (DR) is the leading cause of blindness in the working age worldwide. Although panretinal photocoagulation (PRP) was standard treatm...

    Authors: Jinglan Li, Xuanlong Li, Mingxing Lei, Wanyue Li, Wenqian Chen, Tianju Ma, Yi Gao, Zi Ye and Zhaohui Li
    Citation: Diabetology & Metabolic Syndrome 2022 14:124
  13. Gaussian graphical models (GGM) are an innovative method for deriving dietary networks which reflect dietary intake patterns and demonstrate how food groups are consuming in relation to each other, independent...

    Authors: Reihaneh Jahanmiri, Kurosh Djafarian, Nasim Janbozorgi, Fatemeh Dehghani-Firouzabadi and Sakineh Shab-Bidar
    Citation: Diabetology & Metabolic Syndrome 2022 14:123
  14. Diabetes-induced chronic hyperglycemia results in the formation and aggregation of advanced glycation end-products (AGEs), which are products of non-enzymatic glycosylation of lipids or proteins. The developme...

    Authors: Mohaddeseh Rezaei, Soghra Rabizadeh, Maryam Mirahmad, Minoo Sadat Hajmiri, Manouchehr Nakhjavani, Mahboobeh Hemmatabadi and Nooshin Shirzad
    Citation: Diabetology & Metabolic Syndrome 2022 14:122
  15. Glucose cotransporter (SGLT) 2 suppression provides potent renal protective effect during diabetic kidney disease (DKD). This work aimed to explore how empagliflozin (EMPA, the selective and strong inhibitor o...

    Authors: Hong Sun, Juan Chen, Yulin Hua, Yuyang Zhang and Zheng Liu
    Citation: Diabetology & Metabolic Syndrome 2022 14:121
  16. Type 2 Diabetes mellitus is one of the most common chronic diseases in the world and has many complications. Due to the importance of using alternative therapies in managing symptoms of this disease, the prese...

    Authors: Shima Nematollahi, Gholam Reza Pishdad, Mehrnoosh Zakerkish, Foroogh Namjoyan, Kambiz Ahmadi Angali and Fatemeh Borazjani
    Citation: Diabetology & Metabolic Syndrome 2022 14:120
  17. Metabolic syndrome (MetS) is a cluster of conditions associated with glucose intolerance, hypertension, abdominal obesity, dyslipidemia, and insulin resistance that increase the risk of cardiovascular diseases...

    Authors: Sanghoo Lee, Seol-A Kim, Jeonghoon Hong, Yejin Kim, Gayeon Hong, SaeYun Baik, Kyeonghwan Choi, Mi-Kyeong Lee and Kyoung-Ryul Lee
    Citation: Diabetology & Metabolic Syndrome 2022 14:119
  18. Obesity and related metabolic disorders are associated with genetic and epigenetic alterations. In this study, we have examined the association between polymorphisms and hypermethylation of the CD36 gene promoter...

    Authors: Maïmouna Touré, Aziz Hichami, Amira Sayed, Muhtadi Suliman, Abdoulaye Samb and Naim Akhtar Khan
    Citation: Diabetology & Metabolic Syndrome 2022 14:117
  19. Peripheral and central hemodynamic indices are modifiable by lifestyle and medical intervention. We aimed to determine the long-term effect of intensive multifactorial treatment on peripheral and central hemod...

    Authors: Lasse Bjerg, Esben Laugesen, Signe Toft Andersen, Jonas Frey Rosborg, Morten Charles, Dorte Vistisen and Daniel R. Witte
    Citation: Diabetology & Metabolic Syndrome 2022 14:116
  20. Metabolic dysfunction and associated systemic inflammation are risk factors for chronic obstructive pulmonary disease (COPD) and COPD is highly prevalent in men. We investigated the impact of metabolic-associa...

    Authors: Tsubasa Tsutsumi, Dan Nakano, Machiko Kawaguchi, Ryuki Hashida, Shinobu Yoshinaga, Hirokazu Takahashi, Keizo Anzai and Takumi Kawaguchi
    Citation: Diabetology & Metabolic Syndrome 2022 14:115
  21. The β-cell function and insulin resistance required by existing methods of classifying type 2 diabetes are not routinely adopted in most medical institutions of developing countries and regions. This study aim...

    Authors: Jing Xie, Xin Zhang, Hua Shao, Shenqi Jing, Tao Shan, Yaxiang Shi, Yong Li, Yun Liu and Naifeng Liu
    Citation: Diabetology & Metabolic Syndrome 2022 14:113
  22. With the pandemic of metabolic diseases, nonalcoholic fatty liver disease (NAFLD) prevalence has dramatically elevated. NAFLD encompasses a spectrum of diseases including simple steatosis and nonalcoholic stea...

    Authors: Juan Pang, Ke Chen, Shen Chen and Xu Chen
    Citation: Diabetology & Metabolic Syndrome 2022 14:112
  23. The principal objective of this study was to gain a better understanding of the mechanisms of type 2 diabetes mellitus (T2DM) patients with fatigue (D-T2DM) through exome and transcriptome sequencing.

    Authors: Bohan Lv, Xiuyan Yang, Tian An, Yanxiang Wu, Zhongchen He, Bowu Li, Yijiao Wang, Fang Tan, Tingye Wang, Jiajian Zhu, Yuanyuan Hu, Xiaokun Liu and Guangjian Jiang
    Citation: Diabetology & Metabolic Syndrome 2022 14:111
  24. This study aimed to determine whether a simultaneous diagnosis of main components of metabolic syndrome (MetS) (hypertension, diabetes mellitus, and dyslipidemia) plays a mediator between income level and stroke.

    Authors: Seungmin Jeong, Sung-il Cho and So Yeon Kong
    Citation: Diabetology & Metabolic Syndrome 2022 14:110
  25. Osteocalcin, a protein secreted mainly by mature osteoblasts, has been shown to be involved in glucose metabolism through various pathways. However, few studies has explored the association between osteocalcin...

    Authors: Jun Liu, Yinghua Wei, Pu Zang, Wei Wang, Zhouqin Feng, Yanyu Yuan, Hui Zhou, Zhen Zhang, Haiyan Lei, Xinyi Yang, Jun Liu, Bin Lu and Jiaqing Shao
    Citation: Diabetology & Metabolic Syndrome 2022 14:109
  26. We aimed to investigate changes of bile acids and resting energy expenditure (REE) in patients with type 2 diabetes mellitus (T2DM) after laparoscopic cholecystectomy (LC) and the role in metabolic homeostasis.

    Authors: Haixin Yin, Weijie Chen, Xiaodong He and Jianping Zeng
    Citation: Diabetology & Metabolic Syndrome 2022 14:108
  27. Coronary Heart Disease (CHD) is the leading cause of death in industrialized countries. There is currently no direct relation between CHD and type 2 diabetes mellitus (T2D), one of the major modifiable risk fa...

    Authors: Salma Ahmadloo, King-Hwa Ling, Ahmad Fazli, Ghazaleh Larijani, Nooshin Ghodsian, Sanaz Mohammadi, Naser Amini, Vahid Hosseinpour Sarmadi and Patimah Ismail
    Citation: Diabetology & Metabolic Syndrome 2022 14:107
  28. TCF7L2 rs7903146 and PNPLA3 rs738409 gene variants confer the strongest risk for type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD), respectively. Pancreatic triacylglycerol content (P...

    Authors: Ákos Nádasdi, Viktor Gál, Tamás Masszi, Attila Patócs, Peter Igaz, Anikó Somogyi and Gábor Firneisz
    Citation: Diabetology & Metabolic Syndrome 2022 14:106
  29. Type 2 Diabetes Mellitus (T2DM) patients are twice as likely to develop dementia. The study’s goal was to evaluate cognitive performance and risk factors for cognitive decline in this population.

    Authors: Ana Cristina Ravazzani de Almeida Faria, Joceline Franco Dall’Agnol, Aline Maciel Gouveia, Clara Inácio de Paiva, Victoria Chechetto Segalla and Cristina Pellegrino Baena
    Citation: Diabetology & Metabolic Syndrome 2022 14:105
  30. Type 1 diabetes (T1D) is frequently associated with autoimmune thyroiditis (AT) and coeliac disease (CD). Whether the coexistence of multiple autoimmune diseases increases cardiovascular risk is uncertain. We ...

    Authors: Martina Parise, Antonio Cutruzzolà, Faustina Barbara Scavelli, Claudio Carallo, Agostino Gnasso and Concetta Irace
    Citation: Diabetology & Metabolic Syndrome 2022 14:103
  31. After initiating cardioprotective agents, a fall of estimated glomerular filtration rate (eGFR) has been reported in several studies. Our goal was to evaluate the accuracy of change of Chronic Kidney Disease E...

    Authors: Julie Kolwelter, Kristina Striepe, Agnes Bosch, Dennis Kannenkeril, Christian Ott, Mario Schiffer and Roland E. Schmieder
    Citation: Diabetology & Metabolic Syndrome 2022 14:102
  32. Dengue, an arboviral disease is a global threat to public health as the number of Dengue cases increases through the decades and this trend is predicted to continue. Non-communicable diseases such as diabetes ...

    Authors: S. D. Sekaran, Z. M. Liew, H. C. Yam and C. S. Raju
    Citation: Diabetology & Metabolic Syndrome 2022 14:101
  33. Phthalates exposure and complete edentulism are related to both low socioeconomic status. No study by far has verified if and to what extent these two conditions are related. We aimed to explore their potentia...

    Authors: Alessandro Mengozzi, Fabrizia Carli, Samantha Pezzica, Edoardo Biancalana, Amalia Gastaldelli and Anna Solini
    Citation: Diabetology & Metabolic Syndrome 2022 14:100
  34. Pancreatic β-cell dysfunction is commonly observed in patients with type 2 diabetes mellitus. Protein arginine methyltransferase 1 (PRMT1) plays an important role in pancreatic β-cell dysfunction. However, the...

    Authors: Lixia Lv, Xiumin Wang, Jinhua Shen, Ying Cao and Qin Zhang
    Citation: Diabetology & Metabolic Syndrome 2022 14:99
  35. Authors: Hanan Khudhair Hussein, Nassrin Malik Aubead, Hamzah H. Kzar, Yasir Salam Karim, Ali H. Amin, Moaed E. Al-Gazally, Tousief Irshad Ahmed, Mohammed Abed Jawad, Ali Thaeer Hammid, Abduladheem Turki Jalil, Yasser Fakri Mustafa, Marwan Mahmood Saleh and Hafez Heydari
    Citation: Diabetology & Metabolic Syndrome 2022 14:97

    The original article was published in Diabetology & Metabolic Syndrome 2022 14:74

  36. Metabolic syndrome (MetS) is a clustering of metabolic risk factors, including large waist circumference (WC). Other anthropometric parameters and visceral fat mass (VFM) predicted from these may improve MetS ...

    Authors: John D. Sluyter, Lindsay D. Plank and Elaine C. Rush
    Citation: Diabetology & Metabolic Syndrome 2022 14:96
  37. Over the past two decades, several studies have focused on the association between a common polymorphism (rs1800795) from interleukin-6 (IL-6) gene and Diabetes Mellitus (DM) risk. However, the results remain amb...

    Authors: Zhiying Cheng, Chunmin Zhang and Yuanyuan Mi
    Citation: Diabetology & Metabolic Syndrome 2022 14:95
  38. Foods have a considerable influence on human health and were directly related to glycemic control for diabetes patients. However, little is known about the effects of biscuits, a traditional food consumed in l...

    Authors: Ke Shi, Yuhong Chen, Xinyue Zhu, Jiali Wu, Jieqiong Chen, Jing Hu, Xiaodong Sun and Jingfa Zhang
    Citation: Diabetology & Metabolic Syndrome 2022 14:94
  39. The prevalence of gestational diabetes mellitus [GDM] and of its most important predisposing factor, i.e. overweight and obesity, have increased dramatically over the past 20 years. Therefore, the aim of this ...

    Authors: Sepideh Mashayekh-Amiri, Sakineh Mohammad-Alizadeh-Charandabi, Somaiyeh Abdolalipour and Mojgan Mirghafourvand
    Citation: Diabetology & Metabolic Syndrome 2022 14:93
  40. Studies suggested elevated serum uric acid (SUA) levels are associated with metabolic syndrome (MetS). However, it remains unclear whether baseline SUA and temporal changes predict MetS. The study aimed to inv...

    Authors: Xuan Feng, Yi Guo, Huakang Tu, Shu Li, Chen Chen, Mingxi Sun, Sicong Wang, Bohan Li, Xifeng Wu and Zhenya Song
    Citation: Diabetology & Metabolic Syndrome 2022 14:92
  41. One hour plasma glucose concentration (1hPG) during an oral glucose tolerance test (OGTT) may be an alternative to 2-h plasma glucose concentration (2hPG) in the identification of individuals at increased risk...

    Authors: Vanessa Guerreiro, Isabel Maia, João Sérgio Neves, Daniela Salazar, Maria João Ferreira, Fernando Mendonça, Maria Manuel Silva, Marta Borges-Canha, Sara Viana, Cláudia Costa, Jorge Pedro, Ana Varela, Eva Lau, Paula Freitas and Davide Carvalho
    Citation: Diabetology & Metabolic Syndrome 2022 14:91
  42. To investigate the potential of employing sublingual microcirculation as an early noninvasive screening technique for diabetic nephropathy (DN).

    Authors: Qiang Li, XiaoXiao Liu, Mengxiao Jia, Fang Sun, Yingsha Li, Hexuan Zhang, Xiaoli Liu, Hongbo He, Zhigang Zhao, Zhencheng Yan and Zhiming Zhu
    Citation: Diabetology & Metabolic Syndrome 2022 14:90
  43. Recently, ferroptosis has been implicated in the pathologic process of several diseases including type 2 diabetes mellitus (T2DM). However, molecular mechanisms underlying ferroptosis in T2DM remain obscure.

    Authors: Shanshan Zhang, Xiao Liu, Jihong Wang, Fengjuan Yuan and Yali Liu
    Citation: Diabetology & Metabolic Syndrome 2022 14:89
  44. There has been a longstanding interest in the potential effect of vitamin D in preventing cardiac-metabolic diseases. However, there are divergent results regarding the impact of vitamin D supplementation (VDS...

    Authors: Mostafa Qorbani, Maryam Zarei, Yousef Moradi, Geeta Appannah, Shirin Djalainia, Kumars Pourrostami, Hanieh-Sadat Ejtahed, Armita Mahdavi-Gorabi, Ebrahim Khalil Naderali and Maryam Khazdouz
    Citation: Diabetology & Metabolic Syndrome 2022 14:88
  45. Women with GDM have a higher risk of future cardiovascular diseases (CVD). Meanwhile, synbiotics have been demonstrated to have favorable impacts on atherogenic indices, and inflammatory and oxidative stress i...

    Authors: Zohoor Nabhani, Cain C. T. Clark, Nazanin Goudarzi, Alemeh Hariri Far and Elham Razmpoosh
    Citation: Diabetology & Metabolic Syndrome 2022 14:87

New Content Item

The official journal of the Brazilian Diabetes Society.

Annual Journal Metrics